92 results match your criteria: "The Retina Institute[Affiliation]"
Ophthalmol Retina
March 2017
The Retina Institute, St. Louis, Missouri. Electronic address:
Purpose: To review a population of degenerative retinoschisis (RS) patients, with attention to those with schisis cavity breaks and with retinal detachment complicating retinoschisis (RDRS), to identify management considerations and incidence for this rare clinical entity.
Design: Retrospective chart review of patients with RS and schisis cavity breaks over a 15-year period in a tertiary, multiple-physician vitreoretinal practice.
Subjects: A total of 587 cases of RS were confirmed on chart review, with 59 meeting inclusion criteria.
Brain
November 2016
Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
Can J Ophthalmol
April 2016
The Retina Institute, St. Louis, Mo. Electronic address:
Objective: To assess the efficacy and safety of intravitreal aflibercept injection in the treatment of CNV secondary to presumed ocular histoplasmosis syndrome (POHS).
Purpose: To assess safety of intravitreal aflibercept for the treatment of CNV secondary to presumed ocular histoplasmosis syndrome.
Methods: Masked, open-label, prospective study.
Purpose: Retinoschisis and retinal detachments are primarily differentiated based on characteristic examination findings. In diagnostically challenging cases, noncontact wide-field infrared imaging can help diagnosis and visualize the extent/margins of retinoschisis, retinal detachment, or combined schisis detachments by comparing reflectivity patterns.
Methods: This is a retrospective, observational, descriptive case series of 14 eyes of 14 nonconsecutive patients, ranging from 28 to 89 years old (mean 61), diagnosed with retinoschisis, retinal detachment, or schisis detachment from May 5, 2014 to March 4, 2015.
Retina
January 2016
Departments of *Ophthalmology and Visual Sciences, and †Pathology, W.K. Kellogg Eye Center, University of Michigan, VA Ann Arbor Healthsystem, Ann Arbor, Michigan ‡The Retina Institute, St. Louis, Missouri.
Retina
February 2016
The Retina Institute, St. Louis, Missouri.
Purpose: To evaluate the frequency and type of perioperative hemorrhagic complications associated with vitreoretinal surgery in patients undergoing systemic treatment with the newer anticoagulant and antiplatelet agents including rivaroxaban, apixaban, dabigatran, and prasugrel.
Methods: Retrospective review of a cohort of patients being treated with anticoagulant and antiplatelet drugs, who underwent any vitreoretinal surgical procedure over a 2-year period.
Results: Thirty-six eyes of 33 patients were identified who underwent vitreoretinal surgical operations while being treated systemically with anticoagulant and antiplatelet therapy.
JAMA Ophthalmol
December 2015
The Retina Institute, St Louis, Missouri3Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri.
J Clin Anesth
June 2015
Retina Service, WK Kellogg Eye Center, Department of Ophthalmology & Visual Sciences, Department of Pathology, University of Michigan Medical School, VA Ann Arbor Healthcare System, 1000 Wall St, Brehm 8326, Ann Arbor, MI 4810. Electronic address:
Postoperative visual loss from any cause is potentially catastrophic. We present a case of Valsalva hemorrhagic retinopathy (VHR) as a rare cause of impaired vision after an apparently uneventful general anesthetic. Previously published cases of VHR, anesthetic related and otherwise, are reviewed and the phenomenon discussed.
View Article and Find Full Text PDFRetina
March 2015
*Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida; †LuEster T. Mertz Retinal Research Center, Manhattan Eye Ear and Throat Hospital; and Vitreous Retina Macula Consultants of New York, New York, New York; ‡Department of Ophthalmology, Columbia University, New York, New York; §The Retina Institute, St. Louis, Missouri; and ¶Department of Ophthalmology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
Background: To report the presence of transient peripapillary serous detachments in multiple evanescent white dot syndrome.
Methods: Retrospective case series.
Results: Four eyes of four patients diagnosed with multiple evanescent white dot syndrome presented with peripapillary serous detachments.
Graefes Arch Clin Exp Ophthalmol
April 2015
The Retina Institute, 1600 S. Brentwood Blvd., Suite 800, St. Louis, MO, 63144, USA,
Purpose: The optimal management approach to retinal arterial macroaneurysms (RAM) is unknown. This paper compares long-term outcomes in RAM treated with laser therapy versus observation.
Methods: This is an IRB-approved retrospective study of patients with symptomatic RAM.
Ophthalmology
October 2014
Department of Clinical Science "Luigi Sacco," Sacco Hospital, University of Milan, Milan, Italy.
Purpose: Paraproteinemia relates to monoclonal gammopathy-producing pathologic antibodies with serous macular detachment being an uncommon ocular manifestation. We ascertained the clinical course of maculopathy in paraproteinemia and investigated the effect of various therapeutic methods on the resolution of subretinal deposits.
Design: Multicenter, retrospective, observational case series.
Retina
June 2014
*The Retina Institute/Retina Consultants, St Louis, Missouri; and †Minnesota Eye Consultants, Minneapolis, Minnesota.
Purpose: To review the specific challenges and pitfalls that vitreoretinal surgeons may face when operating on eyes with presbyopia-correcting intraocular lenses or previous corneal refractive surgery. In addition, this review aims to familiarize vitreoretinal surgeons with specifications of currently available Food and Drug Administration-approved presbyopia-correcting intraocular lenses.
Methods: Review of current literature performed with PubMed for search terms "presbyopia," "correction," "IOL," "vitreoretinal," "challenges," and "surgical" both singly and in combination as well as closely related terms.
Int J Ophthalmol
March 2014
Vitreoretinal Service, Cole Eye Institute, Cleveland Clinic, Cleveland 44195, USA.
Aim: To compare the efficacy of ranibizumab and bevacizumab for macular edema due to retinal vein occlusion (RVO).
Methods: A retrospective study was conducted at a single academic institution. Eighty-one patients naïve to anti-VEGF therapy with RVO and macular edema were identified.
Ophthalmology
May 2013
The Retina Institute, St Louis, Missouri, USA.
Ophthalmic Surg Lasers Imaging Retina
July 2013
The Retina Institute, 1600 S. Brentwood Blvd., Suite 800, St. Louis, MO 63144, USA.
Background And Objective: To evaluate the efficacy of ranibizumab in the treatment of choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
Patients And Methods: Patients enrolled in the ranibizumab group received a monthly intravitreal injection of 0.5 mg of ranibizumab.
Purpose: Indocyanine green (ICG) angiograms of each of five patients with retinal pigment epithelium (RPE) detachments were made using first a Topcon fundus camera and then a Heidelberg scanning laser ophthalmoscope (SLO); for each patient, both types of angiograms were obtained on the same day. In each case, the serous fluid appeared bright throughout the fundus camera studies and dark throughout the SLO studies. This study sought to explain the disparity in the appearance of the lesions in the two kinds of images and to determine whether there was dye in the serous fluid.
View Article and Find Full Text PDFRetina
February 1998
Retina Specialists, The Retina Institute of Maryland, Baltimore, MD, USA.
Purpose: To evaluate the visual and anatomic results of macular hole surgery in eyes that have had symptoms of a macular hole for 2 years or longer.
Methods: Fifty-one eyes with chronic macular holes (> or = 2 years' duration) were treated in a retrospective analysis of the results of vitrectomy, 16% perfluoropropane gas tamponade, and one of three adjunctive agents (bovine transforming growth factor beta-2, recombinant transforming growth factor beta-2, or autologous platelet extract). Of 51 eyes, 45 (88.